Ricky Goldwasser
Stock Analyst at Morgan Stanley
(3.26)
# 1,053
Out of 4,761 analysts
246
Total ratings
63.58%
Success rate
7.87%
Average return
Main Sectors:
Stocks Rated by Ricky Goldwasser
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRL Charles River Laboratories International | Maintains: Equal-Weight | $220 → $184 | $163.02 | +12.87% | 20 | Feb 5, 2025 | |
| LH Labcorp Holdings | Maintains: Overweight | $260 → $270 | $249.85 | +8.06% | 15 | Dec 17, 2024 | |
| ACCD Accolade | Maintains: Equal-Weight | $6 → $5 | $6.93 | -27.85% | 17 | Dec 17, 2024 | |
| DOCS Doximity | Upgrades: Equal-Weight | $33 → $53 | $72.37 | -26.77% | 9 | Nov 14, 2024 | |
| UNH UnitedHealth Group | Maintains: Overweight | $615 → $610 | $466.42 | +30.78% | 15 | Oct 16, 2024 | |
| LFST LifeStance Health Group | Reiterates: Overweight | $10 | $7.70 | +29.87% | 8 | Apr 22, 2024 | |
| GDRX GoodRx Holdings | Maintains: Equal-Weight | $8 → $5.5 | $4.81 | +14.35% | 9 | Nov 10, 2023 | |
| OSCR Oscar Health | Maintains: Equal-Weight | $5 → $7.5 | $14.82 | -49.39% | 6 | Aug 30, 2023 | |
| ALHC Alignment Healthcare | Maintains: Overweight | $19 → $12 | $13.18 | -8.95% | 8 | Aug 30, 2023 | |
| CNC Centene | Downgrades: Equal-Weight | $94 → $73 | $57.68 | +26.56% | 10 | Aug 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $145 | $172.24 | -15.82% | 17 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $365 | $283.81 | +28.61% | 7 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $403 → $420 | $597.71 | -29.73% | 27 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $140 → $120 | $11.74 | +922.15% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $549 → $620 | $255.91 | +142.27% | 11 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $485 → $500 | $385.10 | +29.84% | 2 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $127 → $124 | $63.48 | +95.34% | 9 | Oct 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $296 → $318 | $299.81 | +6.07% | 11 | Aug 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $74 → $70 | $127.06 | -44.91% | 17 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $43 → $39 | $10.16 | +283.86% | 15 | Jul 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $182 → $195 | $191.04 | +2.07% | 6 | Oct 21, 2020 |
Charles River Laboratories International
Feb 5, 2025
Maintains: Equal-Weight
Price Target: $220 → $184
Current: $163.02
Upside: +12.87%
Labcorp Holdings
Dec 17, 2024
Maintains: Overweight
Price Target: $260 → $270
Current: $249.85
Upside: +8.06%
Accolade
Dec 17, 2024
Maintains: Equal-Weight
Price Target: $6 → $5
Current: $6.93
Upside: -27.85%
Doximity
Nov 14, 2024
Upgrades: Equal-Weight
Price Target: $33 → $53
Current: $72.37
Upside: -26.77%
UnitedHealth Group
Oct 16, 2024
Maintains: Overweight
Price Target: $615 → $610
Current: $466.42
Upside: +30.78%
LifeStance Health Group
Apr 22, 2024
Reiterates: Overweight
Price Target: $10
Current: $7.70
Upside: +29.87%
GoodRx Holdings
Nov 10, 2023
Maintains: Equal-Weight
Price Target: $8 → $5.5
Current: $4.81
Upside: +14.35%
Oscar Health
Aug 30, 2023
Maintains: Equal-Weight
Price Target: $5 → $7.5
Current: $14.82
Upside: -49.39%
Alignment Healthcare
Aug 30, 2023
Maintains: Overweight
Price Target: $19 → $12
Current: $13.18
Upside: -8.95%
Centene
Aug 30, 2023
Downgrades: Equal-Weight
Price Target: $94 → $73
Current: $57.68
Upside: +26.56%
Aug 3, 2023
Reiterates: Equal-Weight
Price Target: $145
Current: $172.24
Upside: -15.82%
Jul 14, 2023
Reiterates: Overweight
Price Target: $365
Current: $283.81
Upside: +28.61%
Jan 6, 2023
Maintains: Overweight
Price Target: $403 → $420
Current: $597.71
Upside: -29.73%
Jan 6, 2023
Maintains: Overweight
Price Target: $140 → $120
Current: $11.74
Upside: +922.15%
Oct 31, 2022
Maintains: Overweight
Price Target: $549 → $620
Current: $255.91
Upside: +142.27%
Oct 21, 2022
Maintains: Equal-Weight
Price Target: $485 → $500
Current: $385.10
Upside: +29.84%
Oct 11, 2022
Maintains: Overweight
Price Target: $127 → $124
Current: $63.48
Upside: +95.34%
Aug 17, 2022
Maintains: Overweight
Price Target: $296 → $318
Current: $299.81
Upside: +6.07%
Jul 14, 2022
Maintains: Overweight
Price Target: $74 → $70
Current: $127.06
Upside: -44.91%
Jul 6, 2022
Maintains: Underweight
Price Target: $43 → $39
Current: $10.16
Upside: +283.86%
Oct 21, 2020
Maintains: Overweight
Price Target: $182 → $195
Current: $191.04
Upside: +2.07%